Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.68 CAD | -0.54% |
|
+5.75% | -31.47% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.47% | 95.94M | |
+26.00% | 46.56B | |
+45.55% | 41.67B | |
-0.23% | 41.16B | |
+34.24% | 32.4B | |
+20.66% | 28.18B | |
-6.35% | 28.1B | |
+49.04% | 14.52B | |
+47.43% | 13.74B | |
+1.87% | 12.17B |
- Stock Market
- Equities
- EPRX Stock
- News Eupraxia Pharmaceuticals Inc.
- Eupraxia Pharmaceuticals Inc. Brief: Announcing New "Positive" Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis